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Sudden cardiac death (SCD) in a young athlete is a devas-
tating event. There has thus been strong interest in screening
athletes for disorders associated with a high risk of SCD
before athletic participation. The attraction of adding a
resting 12-lead electrocardiogram (ECG) to the screening
process lies in the noninvasive nature of this modality to
detect conditions associated with exercise-induced cardiac
arrhythmias and SCD.
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Both the American Heart Association (AHA) (1) and the
European Society of Cardiology (ESC) (2) have proposed
guidelines for pre-participation screening for young athletes
planning to begin competitive sports. The obvious difference
between these two proposals is that the AHA guidelines
recommend a pre-participation history and physical exami-
nation for general screening but not routine use of ECGs.
The rationale for the AHA objection to universal ECG
screening involves the risk of false-positive results, leading to
anxious moments for the athletes and their families and the
need for further testing. In addition, such a national
screening program would have a substantial impact on the
feasibility and the cost-effectiveness of screening a large U.S.
population of young athletes. The ESC guidelines, on the
other hand, include a standard 12-lead ECG, based on a
national screening program that has been in effect in Italy
since 1982.
Although the value of ECG screening in competitive
athletes continues to be debated, the reality is that most
individuals are sedentary or at most recreational athletes.
In this issue of the Journal, Chandra et al. (3) investigated
the prevalence of potentially abnormal ECG patterns in
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athlete was deﬁned as an individual not involved in regular
competitive team or individual sports, including sedentary
individuals and those exercising recreationally. The subjects
in the study were self-selected and were not required to have
any concerns in their medical history or worrisome symp-
toms to participate. An athlete was deﬁned as an individual
competing at the regional, national, or international level.
ECGs were analyzed for group 1 (training-related) and
group 2 (potentially pathological) patterns as described in the
2010 ESC paper (2). Group 1 ECG changes included sinus
bradycardia, ﬁrst-degree atrioventricular block, incomplete
right bundle-branch block, early repolarization, and isolated
QRS voltage criteria for left ventricular hypertrophy. Group
2 ECG changes included T-wave inversion, ST-segment
depression, pathological Q waves, left or right atrial
enlargement, left- or right-axis deviation, right ventricular
hypertrophy, ventricular pre-excitation, right bundle-branch
block, left bundle-branch block, long QTc, short QTc, and
Brugada-like pattern.
Group 1 ECG patterns, not surprisingly, were highly
prevalent among athletes and quite common as well in the
non-athlete group (87.4% vs. 49.1%). This ﬁnding might
be explained by the fairly active nature of the non-athlete
group (60.1% active for <4 h/week, and 39.1% active for
>4 h/week), rendering it a mixture of recreational athletes
and more sedentary individuals rather than a purely non-
athlete group. Many of the non-athletes had group 1
changes, and, because these are not thought to require further
investigation, this ﬁnding is not critical to the debate on
ECG screening. On the other hand, group 2 ECG patterns
were commonly present in both cohorts, although they were
more common in athletes (33.0% vs. 21.8% in non-athletes).
More than half of the group 2 abnormalities detected in non-
athletes were QTc extremes, both short and long. The rest
of the abnormalities were almost evenly split among atrial
enlargement, axis deviation, right ventricular hypertrophy,
and T-wave inversion.
Echocardiographic evaluation of all 784 non-athletes with
group 2 ECG patterns suggestive of a cardiomyopathy or
structural cardiac abnormality identiﬁed a normal heart in
the majority (84%) of individuals. Only 2% (n ¼ 16) of non-
athletes with group 2 ECG patterns had echocardiographic
ﬁndings that could be consistent with a mild cardiomyop-
athy, and the rest had incidental ﬁndings that would not
affect sports participation.
As mentioned above, the most common group 2 ECG
patterns found in non-athletes were a combination of long-
and short-QTc intervals. This ﬁnding is in contrast with
reports by Corrado et al. (2) and Pelliccia et al. (4) demon-
strating a low prevalence of QTc prolongation (0.69% and
0.003%, respectively). The cut-off values of 440 ms (men)
and 460 ms (women) proposed in the ESC criteria appear
to result in a high frequency of false-positives, and higher
cut-off values of 470 ms (men) and 480 ms (women) have
been adopted in the 36th Bethesda Conference guidelines.
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2036In the current study, such higher cutoff values would have
reduced the prevalence of QTc prolongation to 1.2% in
non-athletes and 0.18% in athletes. These are more tolerable
percentages, yet still greater than the reported prevalence
of long-QT syndrome in the general population. More
germane to the point of mass screening, few individuals
would be identiﬁed with QTc intervals >500 ms, which is
the group at highest risk of SCD.
The deﬁnition of short-QT syndrome (SQTS) is also
controversial. Several authors consider QTc intervals shorter
than 360 and 370 ms, when supported by symptoms or
family history, and QTc shorter than 330 ms and 340 ms
(men and women, respectively), in the absence of symptoms
or family history, to be diagnostic of SQTS (5). When the
cut-off value for SQTS was reduced from <380 ms
to <360–370 ms, the prevalence of SQTS in the Chandra
study declined from 6.9% to 1.2% in non-athletes and from
13% to 4.5% in athletes. However, these percentages are
still higher than the true prevalence of SQTS.
The Italian national screening program, which included a
12-lead ECG, reduced the annual incidence of SCD in
young athletes from 3.6 of 100,000 person-years in 1979 to
1980 to 0.4 of 100,000 person-years in 2003 to 2004 (89%
reduction) (6). An important limitation of this study is that
it compared data from the 2 years preceding implementation
of the screening program with data from the subsequent 2
decades with no controlled comparison of screening versus
non-screening in athletes.
In the United States, Maron et al. (7) reported that
the SCD rate among high school athletes over a 23-year
period in Minnesota was lower than that reported in Italy
(1/100,000 person-years). ECGs were not part of the
screening strategy used in the United States during that
period. Other estimates of event rates in the United States
are as low as 0.44 of 100,000. With these low event rates, a
large-scale ECG screening program before participation in
sports would clearly not be cost-effective. The annual cost
of a mass screening program that includes a prescreening
ECG was estimated at $2 billion per year in the 2007 AHA
report. Given that 21.8% of the entire population of recre-
ational athletes and sedentary individuals is a much larger
number of people than 33.0% of elite athletes, all these
ﬁgures would be substantially higher if we were to institute
mass ECG screening in young individuals.
With respect to screening in speciﬁc populations within
the non-athlete group, a key point to remember is thatwomen have a much lower incidence of exercise-related
death, estimated at 1 of 769,000 in one study (8). Thus,
mass ECG screening of women would be even more difﬁcult
to justify. On the other hand, hypertrophic cardiomyopathy
is more often found in African-American athletes than
in other demographic groups. It is less certain when ECG
screening might be considered to be of value in these
individuals.
Despite the tragedy of losing even one young individual
to SCD, mass ECG screening programs before sports
participation, especially in recreational athletes, are neither
cost-effective nor sustainable. The most common ﬁnding by
far is a false positive test result leading to additional testing
before most individuals are found to be normal and cleared
to exercise. The best way to avoid that scenario is not to
screen with the use of ECGs in the ﬁrst place.
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